Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma Nov 30, 2021
Kintara Presents Updates on Two Phase 2 Clinical Studies at the 2021 Society for Neuro-oncology Annual Meeting Nov 18, 2021
Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update Nov 15, 2021
Kintara Therapeutics to Present at the Q4 Investor Summit Virtual Conference on November 17, 2021 Nov 11, 2021
Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update Sep 29, 2021
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market Sep 24, 2021
Kintara Reports Topline Results from Phase 2 Clinical Study of VAL-083 as Adjuvant Therapy for Newly-Diagnosed GBM Patients Sep 22, 2021
